MedTrace Logo

Pilot Study on the Effect of High Clopidogrel Maintenance Dosing

NCT01118793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2022-11-23

No results posted yet for this study

Summary

This is a Scripps pilot study on the effect of high clopidogrel maintenance dosing and its relationship to cytochrome P450 2C19 polymorphism status \[STSI/CTSA\].

Conditions

Interventions

DRUG

Clopidogrel

150 mg dosage of Clopidogrel for 7 to 10 days.

Sponsors & Collaborators

  • National Center for Research Resources (NCRR)

    collaborator NIH

  • Scripps Health

    lead OTHER

Principal Investigators

  • Colin Barker, MD · Scripps Health

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01118793 on ClinicalTrials.gov